Novo Nordisk, Sanofi, GSK Present Diabetes Data

The European Association for the Study of Diabetes (EASD) annual meeting will take place in Berlin on Oct. 1-5. Novo Nordisk will present data from the Phase III program of its basal insulin Tresiba that is under FDA and European regulatory review for type I and type II diabetes.

Read more>>

Bloomberg BRIEF Newsletters